Healio

GLP-1s may reduce all-cause mortality, adverse events in sickle cell disease

GLP-1 receptor agonist use appeared linked to significantly reduced all-cause mortality among people with sickle cell disease ...
Medscape

Sickle Cell Trait Widely Misinterpreted As Cause of Death

Contrary to misconceptions among medical professionals and patients alike, individuals born with sickle cell trait (SCT) show no risk of experiencing the acute pain crises known to occur with sickle ...
Medscape

Gene-Edited Cells Alleviate Pain Crisis in Sickle Cell Disease

Exagamglogene autotemcel (exa-cel), a CRISPR/Cas9 gene-edited cell therapy, eliminated vaso-occlusive crises in 97% of participants with severe sickle cell disease. The therapy led to substantial ...
The Conversation

Dave Onawelo and Wayne Bayley died from sickle cell crises – what needs to change so others might live?

Funmi Dasaolu receives funding from The National Institute for Health and Care Research. Stephen Hibbs receives funding from the Wellcome Trust. In December 2023, 34-year-old Dave Onawelo told staff ...